Bio-Techne (TECH): analysis and statistics
Return, volatility, Sharpe ratio and risk for Bio-Techne, a component of the S&P 500 in the Health Care. Data as of 2026-10-29.
| Last close price | $72.69 |
| Sector (GICS) | Health Care |
| Annualized return (3.0 yr) | +7.44% |
| Total return over period | +23.87% |
| Annualized volatility | 41.56% |
| Period volatility | 71.80% |
| Period T-bill | 12.40% |
| Sharpe ratio | 0.16 |
| Sortino ratio | 0.24 |
| Max drawdown | -48.07% |
| CVaR 95% (avg. loss, worst 5% of days) | -5.78% |
| Correlation with the S&P 500 | 0.39 |
| Period range | $43.22 – $83.23 |
| Trading days analyzed | 752 |
Over the last 3.0 years, Bio-Techne (TECH) has posted an annualized return of +7.44% with annual volatility of 41.56%, a Sharpe ratio of 0.16. Its worst stretch (max drawdown from a peak) was -48.07%. Its correlation with the S&P 500 is 0.39, which means it moves fairly independently of the index, useful for diversification.
These are historical, realized metrics, not projections: they describe how the stock behaved, not how it will behave going forward. To see how TECH would fit inside an optimized portfolio alongside other stocks, try the optimizer.
Optimize a portfolio with TECH →
Other Health Care stocks
Is it part of the S&P 500?
Yes, Bio-Techne (TECH) is of the S&P 500.
What is the Sharpe ratio? · How to optimize an investment portfolio